Stay updated on Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial page.

Latest updates to the Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance or UI build change rather than an update to study information.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.5.2 replaces the previous v3.5.0 on the page.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedSite revision updated to v3.5.0 with v3.4.3 removed.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This change updates the page version history.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now displays Revision: v3.4.2 and removes the earlier funding-status notice and Revision: v3.4.1. The core study details and navigation remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check91 days agoChange DetectedAdded a general funding notice with a v3.4.1 update. Removed the 'Type 1 diabetes' topic and related items (MedlinePlus Genetics) tied to the prior v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial page.